Stocks · Korea 0082N0 KOSDAQ

Kanaph Therapeutics

13,140원 +2.10% Market cap 1,748억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 6 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—

PBR11.58x

EPS0 KRW

BPS1,135 KRW

ROE-287.27%

Dividend yield0.00%

DPS0 KRW

Payout ratio—

Returns and 52-week range

1W-19.77%

1M-38.62%

YTD-57.91%

52W high70,000원

52W low20,600원

From 52W high-69.57%

Financial results (separate)

Period	Revenue	Operating income	Net income	OP margin
2025	56억	-43억	-356억	-76.8%
Quarterly
2026 1Q	78,157,037원	-54억	-53억	-6,937.1%

Company

CEO이병철

Founded2019-02-14

Fiscal year end12

Websitewww.kanaphtx.com

Address: 서울특별시 용산구 이태원로55가길 3(한남동, 골든너겟)

Peers in the same sector

Company	Market cap	P/E	P/B	1M
아이텍	1,749억	—	0.89	+10.17%
유수홀딩스	1,729억	10.33	0.52	+0.76%
오르비텍	1,754억	178.62	2.27	+21.60%
제이오	1,710억	—	0.94	+18.53%
헬릭스미스	1,818억	—	1.28	+33.50%
도화엔지니어링	1,676억	22.59	0.65	-7.10%

Recent filings

2026-05-13분기보고서 (2026.03)

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.